Department of Pediatric Surgery, Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China
 Mini Review   
								
																Harnessing Multi-omics and Machine Learning for Predictive Modeling of Cancer Drug Response: Advancing Precision Medicine 
																Author(s): Richard Fernandes*             
								
																
						 The advent of precision medicine has revolutionized oncology by promising tailored therapeutic strategies based on individual patient 
  characteristics. Central to this advancement is the integration of multi-omics data—genomics, transcriptomics, proteomics, and metabolomics— 
  providing a comprehensive understanding of cancer's molecular underpinnings. This study explores the integration of machine learning algorithms 
  for predictive modeling of drug response in cancer patients using a multi-omics approach. By leveraging advanced computational techniques and 
  vast multi-omics datasets, the research aims to enhance the accuracy and efficacy of predicting patient-specific responses to cancer treatments, 
  thereby facilitating personalized medicine. Key challenges such as cancer heterogeneity, high dimensionality of data, and integration of disparate 
  data typ.. Read More»
						  
																DOI:
								10.37421/1948-593X.2024.16.432															  
Journal of Bioanalysis & Biomedicine received 3099 citations as per Google Scholar report